Clene, Inc. (CLNN)
6.56
-0.14
(-2.09%)
USD |
NASDAQ |
May 29, 16:00
6.605
+0.04
(+0.69%)
After-Hours: 20:00
Clene EPS Diluted (Quarterly) : -0.6949 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovelStem International Corp. | -0.0012 |
| Brainstorm Cell Therapeutics, Inc. | -0.1928 |
| Precigen, Inc. | -0.0224 |
| Summit Therapeutics, Inc. | -0.2443 |
| Kezar Life Sciences, Inc. | -0.7838 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.091M |
| Revenue (Quarterly) | 0.015M |
| Total Expenses (Quarterly) | 8.106M |
| Enterprise Value | 93.37M |
| Gross Profit Margin (Quarterly) | -2.27K% |
| Profit Margin (Quarterly) | -53.94K% |
| Earnings Yield | -48.89% |
| Normalized Earnings Yield | -39.34 |